The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sterile Infusions Compounding Pharmacy Market Research Report 2025
Synopsis
There’s a higher risk of infection or serious problems if contaminants get into the medication. So, sterile compounds are made in a special environment with additional requirements to minimize this risk.
The global Sterile Infusions Compounding Pharmacy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sterile Infusions Compounding Pharmacy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sterile Infusions Compounding Pharmacy.
Report Scope
The Sterile Infusions Compounding Pharmacy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sterile Infusions Compounding Pharmacy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sterile Infusions Compounding Pharmacy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
B. Braun
Fresenius Kabi
Kelun Pharma
Otsuka Pharmaceutical
JW Pharmaceutical
Pfizer
Teva Pharmaceutical
Haisco Pharmaceutical Group
King York
Cisen
Lummy
Grand Life Sciences
Medisan
BBCA Pharmaceutical
Biokin Pharmaceutical
Xi'an Libang Pharmaceutical
Lionco Pharmaceutical
China Meheco Kangli
Segment by Type
Anti-infectives
Blood Factors
Immunotherapies
Others
Segment by Application
Consumers Aged 18 and Younger
Consumers Aged 19 to 44
Consumers Aged 45 to 64
Consumers Aged 65 and Older
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sterile Infusions Compounding Pharmacy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
There’s a higher risk of infection or serious problems if contaminants get into the medication. So, sterile compounds are made in a special environment with additional requirements to minimize this risk.
The global Sterile Infusions Compounding Pharmacy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sterile Infusions Compounding Pharmacy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sterile Infusions Compounding Pharmacy.
Report Scope
The Sterile Infusions Compounding Pharmacy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sterile Infusions Compounding Pharmacy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sterile Infusions Compounding Pharmacy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
B. Braun
Fresenius Kabi
Kelun Pharma
Otsuka Pharmaceutical
JW Pharmaceutical
Pfizer
Teva Pharmaceutical
Haisco Pharmaceutical Group
King York
Cisen
Lummy
Grand Life Sciences
Medisan
BBCA Pharmaceutical
Biokin Pharmaceutical
Xi'an Libang Pharmaceutical
Lionco Pharmaceutical
China Meheco Kangli
Segment by Type
Anti-infectives
Blood Factors
Immunotherapies
Others
Segment by Application
Consumers Aged 18 and Younger
Consumers Aged 19 to 44
Consumers Aged 45 to 64
Consumers Aged 65 and Older
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sterile Infusions Compounding Pharmacy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sterile Infusions Compounding Pharmacy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anti-infectives
1.2.3 Blood Factors
1.2.4 Immunotherapies
1.2.5 Others
1.3 Market by Application
1.3.1 Global Sterile Infusions Compounding Pharmacy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Consumers Aged 18 and Younger
1.3.3 Consumers Aged 19 to 44
1.3.4 Consumers Aged 45 to 64
1.3.5 Consumers Aged 65 and Older
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sterile Infusions Compounding Pharmacy Market Perspective (2019-2030)
2.2 Sterile Infusions Compounding Pharmacy Growth Trends by Region
2.2.1 Global Sterile Infusions Compounding Pharmacy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sterile Infusions Compounding Pharmacy Historic Market Size by Region (2019-2024)
2.2.3 Sterile Infusions Compounding Pharmacy Forecasted Market Size by Region (2025-2030)
2.3 Sterile Infusions Compounding Pharmacy Market Dynamics
2.3.1 Sterile Infusions Compounding Pharmacy Industry Trends
2.3.2 Sterile Infusions Compounding Pharmacy Market Drivers
2.3.3 Sterile Infusions Compounding Pharmacy Market Challenges
2.3.4 Sterile Infusions Compounding Pharmacy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sterile Infusions Compounding Pharmacy Players by Revenue
3.1.1 Global Top Sterile Infusions Compounding Pharmacy Players by Revenue (2019-2024)
3.1.2 Global Sterile Infusions Compounding Pharmacy Revenue Market Share by Players (2019-2024)
3.2 Global Sterile Infusions Compounding Pharmacy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sterile Infusions Compounding Pharmacy Revenue
3.4 Global Sterile Infusions Compounding Pharmacy Market Concentration Ratio
3.4.1 Global Sterile Infusions Compounding Pharmacy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sterile Infusions Compounding Pharmacy Revenue in 2023
3.5 Sterile Infusions Compounding Pharmacy Key Players Head office and Area Served
3.6 Key Players Sterile Infusions Compounding Pharmacy Product Solution and Service
3.7 Date of Enter into Sterile Infusions Compounding Pharmacy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sterile Infusions Compounding Pharmacy Breakdown Data by Type
4.1 Global Sterile Infusions Compounding Pharmacy Historic Market Size by Type (2019-2024)
4.2 Global Sterile Infusions Compounding Pharmacy Forecasted Market Size by Type (2025-2030)
5 Sterile Infusions Compounding Pharmacy Breakdown Data by Application
5.1 Global Sterile Infusions Compounding Pharmacy Historic Market Size by Application (2019-2024)
5.2 Global Sterile Infusions Compounding Pharmacy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sterile Infusions Compounding Pharmacy Market Size (2019-2030)
6.2 North America Sterile Infusions Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sterile Infusions Compounding Pharmacy Market Size by Country (2019-2024)
6.4 North America Sterile Infusions Compounding Pharmacy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sterile Infusions Compounding Pharmacy Market Size (2019-2030)
7.2 Europe Sterile Infusions Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sterile Infusions Compounding Pharmacy Market Size by Country (2019-2024)
7.4 Europe Sterile Infusions Compounding Pharmacy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sterile Infusions Compounding Pharmacy Market Size (2019-2030)
8.2 Asia-Pacific Sterile Infusions Compounding Pharmacy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sterile Infusions Compounding Pharmacy Market Size by Region (2019-2024)
8.4 Asia-Pacific Sterile Infusions Compounding Pharmacy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sterile Infusions Compounding Pharmacy Market Size (2019-2030)
9.2 Latin America Sterile Infusions Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sterile Infusions Compounding Pharmacy Market Size by Country (2019-2024)
9.4 Latin America Sterile Infusions Compounding Pharmacy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size (2019-2030)
10.2 Middle East & Africa Sterile Infusions Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size by Country (2019-2024)
10.4 Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baxter
11.1.1 Baxter Company Detail
11.1.2 Baxter Business Overview
11.1.3 Baxter Sterile Infusions Compounding Pharmacy Introduction
11.1.4 Baxter Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024)
11.1.5 Baxter Recent Development
11.2 B. Braun
11.2.1 B. Braun Company Detail
11.2.2 B. Braun Business Overview
11.2.3 B. Braun Sterile Infusions Compounding Pharmacy Introduction
11.2.4 B. Braun Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024)
11.2.5 B. Braun Recent Development
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Detail
11.3.2 Fresenius Kabi Business Overview
11.3.3 Fresenius Kabi Sterile Infusions Compounding Pharmacy Introduction
11.3.4 Fresenius Kabi Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024)
11.3.5 Fresenius Kabi Recent Development
11.4 Kelun Pharma
11.4.1 Kelun Pharma Company Detail
11.4.2 Kelun Pharma Business Overview
11.4.3 Kelun Pharma Sterile Infusions Compounding Pharmacy Introduction
11.4.4 Kelun Pharma Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024)
11.4.5 Kelun Pharma Recent Development
11.5 Otsuka Pharmaceutical
11.5.1 Otsuka Pharmaceutical Company Detail
11.5.2 Otsuka Pharmaceutical Business Overview
11.5.3 Otsuka Pharmaceutical Sterile Infusions Compounding Pharmacy Introduction
11.5.4 Otsuka Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024)
11.5.5 Otsuka Pharmaceutical Recent Development
11.6 JW Pharmaceutical
11.6.1 JW Pharmaceutical Company Detail
11.6.2 JW Pharmaceutical Business Overview
11.6.3 JW Pharmaceutical Sterile Infusions Compounding Pharmacy Introduction
11.6.4 JW Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024)
11.6.5 JW Pharmaceutical Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Sterile Infusions Compounding Pharmacy Introduction
11.7.4 Pfizer Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Detail
11.8.2 Teva Pharmaceutical Business Overview
11.8.3 Teva Pharmaceutical Sterile Infusions Compounding Pharmacy Introduction
11.8.4 Teva Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024)
11.8.5 Teva Pharmaceutical Recent Development
11.9 Haisco Pharmaceutical Group
11.9.1 Haisco Pharmaceutical Group Company Detail
11.9.2 Haisco Pharmaceutical Group Business Overview
11.9.3 Haisco Pharmaceutical Group Sterile Infusions Compounding Pharmacy Introduction
11.9.4 Haisco Pharmaceutical Group Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024)
11.9.5 Haisco Pharmaceutical Group Recent Development
11.10 King York
11.10.1 King York Company Detail
11.10.2 King York Business Overview
11.10.3 King York Sterile Infusions Compounding Pharmacy Introduction
11.10.4 King York Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024)
11.10.5 King York Recent Development
11.11 Cisen
11.11.1 Cisen Company Detail
11.11.2 Cisen Business Overview
11.11.3 Cisen Sterile Infusions Compounding Pharmacy Introduction
11.11.4 Cisen Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024)
11.11.5 Cisen Recent Development
11.12 Lummy
11.12.1 Lummy Company Detail
11.12.2 Lummy Business Overview
11.12.3 Lummy Sterile Infusions Compounding Pharmacy Introduction
11.12.4 Lummy Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024)
11.12.5 Lummy Recent Development
11.13 Grand Life Sciences
11.13.1 Grand Life Sciences Company Detail
11.13.2 Grand Life Sciences Business Overview
11.13.3 Grand Life Sciences Sterile Infusions Compounding Pharmacy Introduction
11.13.4 Grand Life Sciences Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024)
11.13.5 Grand Life Sciences Recent Development
11.14 Medisan
11.14.1 Medisan Company Detail
11.14.2 Medisan Business Overview
11.14.3 Medisan Sterile Infusions Compounding Pharmacy Introduction
11.14.4 Medisan Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024)
11.14.5 Medisan Recent Development
11.15 BBCA Pharmaceutical
11.15.1 BBCA Pharmaceutical Company Detail
11.15.2 BBCA Pharmaceutical Business Overview
11.15.3 BBCA Pharmaceutical Sterile Infusions Compounding Pharmacy Introduction
11.15.4 BBCA Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024)
11.15.5 BBCA Pharmaceutical Recent Development
11.16 Biokin Pharmaceutical
11.16.1 Biokin Pharmaceutical Company Detail
11.16.2 Biokin Pharmaceutical Business Overview
11.16.3 Biokin Pharmaceutical Sterile Infusions Compounding Pharmacy Introduction
11.16.4 Biokin Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024)
11.16.5 Biokin Pharmaceutical Recent Development
11.17 Xi'an Libang Pharmaceutical
11.17.1 Xi'an Libang Pharmaceutical Company Detail
11.17.2 Xi'an Libang Pharmaceutical Business Overview
11.17.3 Xi'an Libang Pharmaceutical Sterile Infusions Compounding Pharmacy Introduction
11.17.4 Xi'an Libang Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024)
11.17.5 Xi'an Libang Pharmaceutical Recent Development
11.18 Lionco Pharmaceutical
11.18.1 Lionco Pharmaceutical Company Detail
11.18.2 Lionco Pharmaceutical Business Overview
11.18.3 Lionco Pharmaceutical Sterile Infusions Compounding Pharmacy Introduction
11.18.4 Lionco Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024)
11.18.5 Lionco Pharmaceutical Recent Development
11.19 China Meheco Kangli
11.19.1 China Meheco Kangli Company Detail
11.19.2 China Meheco Kangli Business Overview
11.19.3 China Meheco Kangli Sterile Infusions Compounding Pharmacy Introduction
11.19.4 China Meheco Kangli Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024)
11.19.5 China Meheco Kangli Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Sterile Infusions Compounding Pharmacy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Anti-infectives
Table 3. Key Players of Blood Factors
Table 4. Key Players of Immunotherapies
Table 5. Key Players of Others
Table 6. Global Sterile Infusions Compounding Pharmacy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Sterile Infusions Compounding Pharmacy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Sterile Infusions Compounding Pharmacy Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Sterile Infusions Compounding Pharmacy Market Share by Region (2019-2024)
Table 10. Global Sterile Infusions Compounding Pharmacy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Sterile Infusions Compounding Pharmacy Market Share by Region (2025-2030)
Table 12. Sterile Infusions Compounding Pharmacy Market Trends
Table 13. Sterile Infusions Compounding Pharmacy Market Drivers
Table 14. Sterile Infusions Compounding Pharmacy Market Challenges
Table 15. Sterile Infusions Compounding Pharmacy Market Restraints
Table 16. Global Sterile Infusions Compounding Pharmacy Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Sterile Infusions Compounding Pharmacy Market Share by Players (2019-2024)
Table 18. Global Top Sterile Infusions Compounding Pharmacy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Infusions Compounding Pharmacy as of 2023)
Table 19. Ranking of Global Top Sterile Infusions Compounding Pharmacy Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Sterile Infusions Compounding Pharmacy Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Sterile Infusions Compounding Pharmacy Product Solution and Service
Table 23. Date of Enter into Sterile Infusions Compounding Pharmacy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Sterile Infusions Compounding Pharmacy Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Sterile Infusions Compounding Pharmacy Revenue Market Share by Type (2019-2024)
Table 27. Global Sterile Infusions Compounding Pharmacy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Sterile Infusions Compounding Pharmacy Revenue Market Share by Type (2025-2030)
Table 29. Global Sterile Infusions Compounding Pharmacy Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Sterile Infusions Compounding Pharmacy Revenue Market Share by Application (2019-2024)
Table 31. Global Sterile Infusions Compounding Pharmacy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Sterile Infusions Compounding Pharmacy Revenue Market Share by Application (2025-2030)
Table 33. North America Sterile Infusions Compounding Pharmacy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Sterile Infusions Compounding Pharmacy Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Sterile Infusions Compounding Pharmacy Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Sterile Infusions Compounding Pharmacy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Sterile Infusions Compounding Pharmacy Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Sterile Infusions Compounding Pharmacy Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Sterile Infusions Compounding Pharmacy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Sterile Infusions Compounding Pharmacy Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Sterile Infusions Compounding Pharmacy Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Sterile Infusions Compounding Pharmacy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Sterile Infusions Compounding Pharmacy Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Sterile Infusions Compounding Pharmacy Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size by Country (2025-2030) & (US$ Million)
Table 48. Baxter Company Detail
Table 49. Baxter Business Overview
Table 50. Baxter Sterile Infusions Compounding Pharmacy Product
Table 51. Baxter Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 52. Baxter Recent Development
Table 53. B. Braun Company Detail
Table 54. B. Braun Business Overview
Table 55. B. Braun Sterile Infusions Compounding Pharmacy Product
Table 56. B. Braun Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 57. B. Braun Recent Development
Table 58. Fresenius Kabi Company Detail
Table 59. Fresenius Kabi Business Overview
Table 60. Fresenius Kabi Sterile Infusions Compounding Pharmacy Product
Table 61. Fresenius Kabi Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 62. Fresenius Kabi Recent Development
Table 63. Kelun Pharma Company Detail
Table 64. Kelun Pharma Business Overview
Table 65. Kelun Pharma Sterile Infusions Compounding Pharmacy Product
Table 66. Kelun Pharma Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 67. Kelun Pharma Recent Development
Table 68. Otsuka Pharmaceutical Company Detail
Table 69. Otsuka Pharmaceutical Business Overview
Table 70. Otsuka Pharmaceutical Sterile Infusions Compounding Pharmacy Product
Table 71. Otsuka Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 72. Otsuka Pharmaceutical Recent Development
Table 73. JW Pharmaceutical Company Detail
Table 74. JW Pharmaceutical Business Overview
Table 75. JW Pharmaceutical Sterile Infusions Compounding Pharmacy Product
Table 76. JW Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 77. JW Pharmaceutical Recent Development
Table 78. Pfizer Company Detail
Table 79. Pfizer Business Overview
Table 80. Pfizer Sterile Infusions Compounding Pharmacy Product
Table 81. Pfizer Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 82. Pfizer Recent Development
Table 83. Teva Pharmaceutical Company Detail
Table 84. Teva Pharmaceutical Business Overview
Table 85. Teva Pharmaceutical Sterile Infusions Compounding Pharmacy Product
Table 86. Teva Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 87. Teva Pharmaceutical Recent Development
Table 88. Haisco Pharmaceutical Group Company Detail
Table 89. Haisco Pharmaceutical Group Business Overview
Table 90. Haisco Pharmaceutical Group Sterile Infusions Compounding Pharmacy Product
Table 91. Haisco Pharmaceutical Group Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 92. Haisco Pharmaceutical Group Recent Development
Table 93. King York Company Detail
Table 94. King York Business Overview
Table 95. King York Sterile Infusions Compounding Pharmacy Product
Table 96. King York Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 97. King York Recent Development
Table 98. Cisen Company Detail
Table 99. Cisen Business Overview
Table 100. Cisen Sterile Infusions Compounding Pharmacy Product
Table 101. Cisen Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 102. Cisen Recent Development
Table 103. Lummy Company Detail
Table 104. Lummy Business Overview
Table 105. Lummy Sterile Infusions Compounding Pharmacy Product
Table 106. Lummy Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 107. Lummy Recent Development
Table 108. Grand Life Sciences Company Detail
Table 109. Grand Life Sciences Business Overview
Table 110. Grand Life Sciences Sterile Infusions Compounding Pharmacy Product
Table 111. Grand Life Sciences Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 112. Grand Life Sciences Recent Development
Table 113. Medisan Company Detail
Table 114. Medisan Business Overview
Table 115. Medisan Sterile Infusions Compounding Pharmacy Product
Table 116. Medisan Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 117. Medisan Recent Development
Table 118. BBCA Pharmaceutical Company Detail
Table 119. BBCA Pharmaceutical Business Overview
Table 120. BBCA Pharmaceutical Sterile Infusions Compounding Pharmacy Product
Table 121. BBCA Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 122. BBCA Pharmaceutical Recent Development
Table 123. Biokin Pharmaceutical Company Detail
Table 124. Biokin Pharmaceutical Business Overview
Table 125. Biokin Pharmaceutical Sterile Infusions Compounding Pharmacy Product
Table 126. Biokin Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 127. Biokin Pharmaceutical Recent Development
Table 128. Xi'an Libang Pharmaceutical Company Detail
Table 129. Xi'an Libang Pharmaceutical Business Overview
Table 130. Xi'an Libang Pharmaceutical Sterile Infusions Compounding Pharmacy Product
Table 131. Xi'an Libang Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 132. Xi'an Libang Pharmaceutical Recent Development
Table 133. Lionco Pharmaceutical Company Detail
Table 134. Lionco Pharmaceutical Business Overview
Table 135. Lionco Pharmaceutical Sterile Infusions Compounding Pharmacy Product
Table 136. Lionco Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 137. Lionco Pharmaceutical Recent Development
Table 138. China Meheco Kangli Company Detail
Table 139. China Meheco Kangli Business Overview
Table 140. China Meheco Kangli Sterile Infusions Compounding Pharmacy Product
Table 141. China Meheco Kangli Revenue in Sterile Infusions Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 142. China Meheco Kangli Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sterile Infusions Compounding Pharmacy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Sterile Infusions Compounding Pharmacy Market Share by Type: 2023 VS 2030
Figure 3. Anti-infectives Features
Figure 4. Blood Factors Features
Figure 5. Immunotherapies Features
Figure 6. Others Features
Figure 7. Global Sterile Infusions Compounding Pharmacy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Sterile Infusions Compounding Pharmacy Market Share by Application: 2023 VS 2030
Figure 9. Consumers Aged 18 and Younger Case Studies
Figure 10. Consumers Aged 19 to 44 Case Studies
Figure 11. Consumers Aged 45 to 64 Case Studies
Figure 12. Consumers Aged 65 and Older Case Studies
Figure 13. Sterile Infusions Compounding Pharmacy Report Years Considered
Figure 14. Global Sterile Infusions Compounding Pharmacy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Sterile Infusions Compounding Pharmacy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Sterile Infusions Compounding Pharmacy Market Share by Region: 2023 VS 2030
Figure 17. Global Sterile Infusions Compounding Pharmacy Market Share by Players in 2023
Figure 18. Global Top Sterile Infusions Compounding Pharmacy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Infusions Compounding Pharmacy as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Sterile Infusions Compounding Pharmacy Revenue in 2023
Figure 20. North America Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Sterile Infusions Compounding Pharmacy Market Share by Country (2019-2030)
Figure 22. United States Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Sterile Infusions Compounding Pharmacy Market Share by Country (2019-2030)
Figure 26. Germany Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Sterile Infusions Compounding Pharmacy Market Share by Region (2019-2030)
Figure 34. China Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Sterile Infusions Compounding Pharmacy Market Share by Country (2019-2030)
Figure 42. Mexico Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Share by Country (2019-2030)
Figure 46. Turkey Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Baxter Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2019-2024)
Figure 49. B. Braun Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2019-2024)
Figure 50. Fresenius Kabi Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2019-2024)
Figure 51. Kelun Pharma Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2019-2024)
Figure 52. Otsuka Pharmaceutical Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2019-2024)
Figure 53. JW Pharmaceutical Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2019-2024)
Figure 54. Pfizer Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2019-2024)
Figure 55. Teva Pharmaceutical Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2019-2024)
Figure 56. Haisco Pharmaceutical Group Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2019-2024)
Figure 57. King York Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2019-2024)
Figure 58. Cisen Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2019-2024)
Figure 59. Lummy Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2019-2024)
Figure 60. Grand Life Sciences Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2019-2024)
Figure 61. Medisan Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2019-2024)
Figure 62. BBCA Pharmaceutical Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2019-2024)
Figure 63. Biokin Pharmaceutical Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2019-2024)
Figure 64. Xi'an Libang Pharmaceutical Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2019-2024)
Figure 65. Lionco Pharmaceutical Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2019-2024)
Figure 66. China Meheco Kangli Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
